May 25, 2023

Opening Remarks & Housekeeping | State of the Union

8:00-8:15 |Palais-Kent

Dr. Tara Graham, Dr. Alessandra Cassano-Bailey, Dr. Veronique Caty, Dr. Gerald Gahide, Dr. Stefan Pryzbojewski

At the end of the session the participant will be able to:

• Describe the accomplishments of CAIR in the previous year
• Summarize the direction of the organization for 2023 and beyond
• Discuss how members can become more involved 

Clinical IR

8:15-8:30 |Palais-Kent

Locoregional Pain Blocks
Speaker(s): Dr. Stefan Pryzbojewski

At the end of the session the participant will be able to:

• Describe the utility of locoregional blocks for decreasing procedure related pain
• Recognize safe approaches and utilize various image guided techniques for performing locoregional blocks, 
• Demonstrate an overview of anatomy, relevant to performing effective locoregional blocks 

8:30-8:45 |Palais-Kent

Locoregional Blocks: Head & Neck 
Speaker(s): Dr. Stefan Pryzbojewski

At the end of the session the participant will be able to:

•  Identify when and what block to perform
• Assess the utilization of US and CT guidance
• Recognize what medications to inject 

8:45-8:55 |Palais-Kent

Osteoarthritis Pain Management – Geniculate Artery Embolization
Speaker(s): Dr. Jason Wong

At the end of the session the participant will be able to:

• Describe the relationship between neoangiogensis and osteoarthritis 
• Discuss the knee arterial anatomy for GAE
• Compare early studies of GAE 

Keynote Spotlight Series

09:00-09:15 |Palais-Kent

CAIR and SIR
Speaker(s): Dr. Parag Patel

At the end of the session the participant will be able to:

• Understand the history and mission of both CAIR and SIR, and how their collaboration can advance the field of interventional radiology in Canada and globally.
• Identify the key opportunities for collaboration between CAIR and SIR
• Gain knowledge and skills for effective collaboration and communication 

09:15-09:30 |Palais-Kent

Device Development for Interventional Oncology Arising from Daily Practice
Speaker(s): Dr. Shinchi Hori

At the end of the session the participant will be able to:

• Identify the technical limitations of currently available devices in the IR suite.
• Develop an effective approach to design of new devices to overcome those technical limitations.
• Understand the different steps required in the development of new devices. 

09:30-09:45 |Palais-Kent

Pelvic Venous Disease: Clinical Approach to Decision Making from Initial Visit to Intervention, Follow-up, and Adjuvant Therapies
Speaker(s): Dr. Spencer Brooke 

At the end of the session the participant will be able to:

• Recognize the pathophysiology of pelvic venous disease
• Develop a clinical approach to the diagnosis and management of pelvic venous disease
• Identify appropriate interventional radiology procedures for the treatment of pelvic venous disease 

9:50-10:20 Break

Debates Series

10:20-10:40 |Palais-Kent

Lipidol vs Beads
Speaker(s): Dr. Jean-Pierre Pelage, Dr. John Kachura

At the end of the session the participant will be able to:

• Differentiate the mechanisms of action and indications for Lipiodol and embolic beads in chemo-embolization procedures.
• Evaluate the safety profiles and potential complications associated with the use of Lipiodol and embolic beads
• Develop an understanding of how to select between Lipiodol and embolic beads 

10:40-11:00 |Palais-Kent

Bronchial Artery Embolization: Glue vs Particles
Speaker(s): Dr. Patrick Gilbert, Dr. Surinder Dhaliwal

At the end of the session the participant will be able to:

• Compare and contrast the use of glue and particles for bronchial artery embolization
• Analyze the patient selection criteria and indications for using glue versus particles for bronchial artery embolization
• Develop a comprehensive treatment algorithm for bronchial artery embolization that incorporates the use of both glue and particles 

11:00-11:20 |Palais-Kent

If I Could Only Invest in One Thermal Technology: Hot vs Cold 
Speaker(s): Dr. David Valenti, Dr. Derek Cool

At the end of the session the participant will be able to:

• Identify the role and opportunity for cryoablation for treatment of cancer and pain in different organ systems.
• Describe the potential benefit of cryoablation over thermal heat ablation for treatment of tumours in kidneys.
• Describe the current oncologic outcomes expected for ablation in organs other than the kidney. 

12:00-13:00 Lunch symposia 

My Best and Worst Day in the Angio Suite: Lessons Learned in the Trenches

13:00-13:20 |Palais-Kent

Speaker(s): Dr. Shinchi Hori

At the end of the session the participant will be able to:

• Recognize and avoid invisible hazards caused by carelessness or ignorance.
• Identify how to obtain the best results through their long experience and careful planning of individual treatment procedures.
• Apply knowledge gained to carry out better procedures with a minimum of risk. 

13:20-13:40 |Palais-Kent

Speaker(s): Dr. Brooke Spencer

At the end of the session the participant will be able to:

• Recognize opportunities to take control of situations to avoid bad outcomes
• Create opportunities to guide care through creative solutions
• Identify learning opportunities from experiences and apply learning to practice  

13:40-14:00 |Palais-Kent

Speaker(s): Dr. Parag Patel

At the end of the session the participant will be able to:

• Identify errors in judgement that lead to patient complications
• Describe how to manage difficult cases in the endovascular suite
• Identify key decisions that allow for optimal patient outcomes   

14:00-14:20 |Palais-Kent

Residents & Fellows’ Best Cases
Speaker(s): Dr. John Kachura, Dr. Melissa Skanes

14:20-14:40 |Palais-Kent

CAIR Award

Speaker(s): Dr. Martin Simons                                                                                

14:40-15:10 Break

Masterclass 1

(concurrent sessions)

15:10-16:10 |Beauport/Beaumont/Bélair

Pelvic Venous & IVC Reconstruction
Speaker(s): Dr. Brooke Spencer, Dr. Ali Bessissow

At the end of the session the participant will be able to:

• Identify the indications and contraindications for pelvic venous and IVC reconstruction
• Describe the various techniques and technologies available for pelvic venous and IVC reconstruction
• Recognize the importance of a multidisciplinary approach to pelvic venous and IVC reconstruction 

15:10-16:10 |St-Louis

Challenging CLI and PAD Cases
Speaker(s): Dr. Mathieu Beland, Dr. Parag Patel

At the end of the session the participant will be able to:

• Identify appropriate treatment options for complex cases of CLI and PAD
• Develop a comprehensive approach to complex CLI and PAD cases
• Manage procedural complications in CLI and PAD interventions 

Opening Reception & Networking

18:00-20:00|Villeray / De Tourny

May 26, 2023

Masterclass 2

(concurrent sessions)

08:00-09:00 |Beauport/Beaumont/Belair

Genius Session
Speaker(s): Dr. Bob Abraham, Shinchi Hori

At the end of the session the participant will be able to:

• Recognize the different steps necessary to develop new interventional devices.
• Develop a bench to bedside approach to design new devices.
• Identify the main hurdles faced when developing new devices. 

08:00-09:00 |St-Louis

Complex Mesenteric Artery Revascularization
Speaker(s): Dr. Simon Bradette, Dr. Jeff Jaskolka

At the end of the session the participant will be able to:

• List some indications for intervention in acute and chronic mesenteric vascular disease
• Describe some advantages and disadvantages of radial and femoral approaches to mesenteric intervention
• Describe several tips and tricks for recanalization of occluded mesenteric vessels. 

9:00-9:30 Break

Embolization

09:30-09:45 |Palais-Kent

Medical Management for Prostatic Hypertrophy
Speaker(s): Dr. Rabi Tiguert

At the end of the session the participant will be able to:

• Understand the BPH CUA guidelines
• Recognize different procedures on BPH
• Describe the minimally invasive techniques  

09:45-10:00 |Palais-Kent

Prostate Artery Embolization Update: Current Evidence and Guidelines
Speaker(s): Dr. Nevin de Korompay

At the end of the session the participant will be able to:

• Review RCT data for PAE
• Compare PAE to other MIST’s
• Understand Canadian PAE context  

10:00-10:10 |Palais-Kent

Transarterial Treatment for Primary Breast Cancer and Lymph Node Metastases
Speaker(s): Dr. Shinchi Hori

At the end of the session the participant will be able to:

• Recognize the role of transarterial treatment for primary breast cancer and lymph node metastases
• Identify the indications and contraindications for transarterial treatment for primary breast cancer and lymph node metastases
• Describe the potential complications and adverse effects associated with transarterial treatment for primary breast cancer and lymph node metastases 

10:10-10:20 |Palais-Kent

Transarterial management of malignant tumors of the lung and mediastinum 
Speaker(s): Dr. Shinchi Hori

At the end of the session the participant will be able to:

• Recognize the effectiveness of TACE in treating advanced lung cancers for which there are no treatment options.
• Use transarterial intervention for lung cancers with limited complications
• Treat lung cancers with favorable results for better quality of life and longer survival rates.   

10:20-10:30 |Palais-Kent

Discussions 

10:30-11:00 Break

New directions in AVM management

11:00-11:20 |Palais-Kent

New Developments in AVM Management
Speaker(s): Dr. Marie-France Giroux, Dr. Martin Simons

At the end of the session the participant will be able to:

• Describe the role of genetic markers in vascular malformations
• Identify new drugs being used or evaluated in treatment of vascular malformations.
• Recognize the role of cryoablation in the treatment of vascular malformations. 

11:20-12:00 |Palais-Kent

Case-Based Expert Discussion
Speaker(s): Dr. Marie-France Giroux, Dr. Martin Simons, Dr. Aziz Qazi

At the end of the session the participant will be able to:

• Describe the role of genetic markers in vascular malformations
• Identify new drugs being used or evaluated in treatment of vascular malformations.
• Recognize the role of cryoablation in the treatment of vascular malformations. 

12:00-13:00 Lunch symposia

Interventions in Women’s Health Multidisciplinary Panel

13:30-13:40 |Palais-Kent

Status of IR referral in Canada: Have We Improved Post-Campaign?
Speaker(s): Dr. Veronique Caty

At the end of the session the participant will be able to:

• Describe current condition of uterine fibroid embolization in Canada
• Identify differences in UFE techniques between sites in Canada
• Analyse issues impacting IR performing UFE across Canada 

13:40-13:55 |Palais-Kent

International UFE Referral Practice: What Can We Learn?
Speaker(s): Dr. Jean-Pierre Pelage

At the end of the session the participant will be able to:

• Identify the different referral pathways available in France
• Describe the differences between referral pathways
• Recognize the impact of scientific evidence on patient referral 

13:55-14:15 |Palais-Kent

Town Hall: UFE across Canada Task Force Selection and Preliminary Goals
Speaker(s): Dr. Jean-Pierre Pelage, Dr. Veronique Caty

At the end of the session the participant will be able to:

• Identify challenges for women with fibroids to access fibroid treatment (UFE) in Canada
• Determine how to improve UFE access across Canada
• Create UFE task force group to maintain and improve UFE access in Canada 

14:15-14:40 Break

CAIR Initiative 2023 « Ask for Ablation »

14:40-14:45 |Palais-Kent

Introduction New Campaign: Ablative Treatments Offered Currently Across Canada (National Survey Baseline Data)
Speaker(s): Dr. Alessandra Cassano-Bailey

At the end of the session the participant will be able to:

• Describe the range of ablative treatments currently available across Canada
• Identify the key stakeholders and audiences for a campaign focused on promoting awareness of ablative treatments
• Express interest in becoming involved with the campaign 

14:45-15:00 |Palais-Kent

Renal Cryoablation Update and Tips and Tricks for Tricky Lesions
Speaker(s): Dr. Derek Cool

At the end of the session the participant will be able to:

• Describe the status of renal cryoablation in treatment of T1a and T1b renal cell carcinoma
• Identify renal tumours at risk for major complication.
• Apply potential corrective/preventative ancillary procedures to increase ablation safety. 

15:00-15:15 |Palais-Kent

Liver Ablation Update
Speaker(s): Dr. Amol Mujoomdar

At the end of the session the participant will be able to:

• Review the latest evidence for thermal ablation in treatment of hepatocellular carcinoma
• Identify the evolving role of ablation in the treatment of metastatic colorectal carcinoma.
• Compare outcomes of percutaneous ablation with other treatment modalities 

15:15-15:30 |Palais-Kent

New Directions: Cryoablation for Breast Lesions
Speaker(s): Dr. Ryan Margau

At the end of the session the participant will be able to:

• Identify breast lesions that are potentially amendable to cryotherapy
• Summarize why a multidisciplinary tumor board discussion is needed before treating a breast lesion with cryoablation
• Develop a treatment plan for ablating a suitable breast lesion 

15:30-15:40 |Palais-Kent

Lung Ablation
Speaker(s): Dr. Gerald Gahide

At the end of the session the participant will be able to:

• Identify appropriate patient selection criteria for lung ablation procedures
• Describe the different types of lung ablation techniques available
• Evaluate the risks and potential complications associated with lung ablation procedures 

CAIR AGM

15:40-15:50 |Palais-Kent

Dr. Tara Graham | Dr. David Valenti

15:50-16:10 Break

Masterclass 3

16:10-17:30 |Palais-Kent

Jeopardy Film Panel
Moderator(s): Dr. Jason Wong, Dr. Nevin de Korompay

At the end of the session the participant will be able to:

• Summarize IR procedures done in the liver 
• Recognize IR procedures done on celebrities 
• Explain IR MSK procedures 

Women in IR – Cocktails & Networking

18:00-19:30 | Plaines

May 27, 2023

Wellness Symposium – Radiation Exposure and Protection in 2023 – SAM Session

08:00-08:45 |Palais-Kent

Radiation Exposure and Protection Update: What You Need to Know
Speaker(s): Dr. Lindsay Machan

At the end of the session the participant will be able to:

• Discuss basic principles of radiation safety
• Recognize newer areas of radiation safety research including anti-oxidants
• Discuss misconceptions about commonly accepted radiation protection manoeuvres.

08:45-09:00 |Palais-Kent

Ophthalmology: Cataract Diagnosis and Treatments
Speaker(s): Dr. Rene Dinh

At the end of the session the participant will be able to:

• Review of the crystalline lens anatomy, mechanisms of cataract formation, diagnosis, treatment, and prognosis 
• Identify the risks of ionizing radiation exposure to the crystalline lens. Learn about physiopathology. 
• Review the specific radioprotection measures to the eye, and dose limit to the eye. 

Discussions

09:00-09:10 Break

Masterclass 4

(concurrent sessions)

9:10-10:10 |Beauport/Beaumont/Bélair

Peds IR for the Adult Interventionist
Speaker(s): Dr. George Koshy Chiramel,  Dr. Jean-Nicolas Racicot

At the end of the session the participant will be able to:

• Recognize the similarities and dissimilarities between pediatric and adult intervention radiology services
• Understand the disease processes pertaining to the specific age groups
• Identify the precautions in planning for a pediatric IR case.  

9:10-10:10 |St-Louis

Spyglass Percutaneous Endobiliary Procedures
Speaker(s): Dr. Ali Bessisow, Dr. Eran Shlomovitz

At the end of the session the participant will be able to:

• Identify the indications for Spyglass Percutaneous Endobiliary Procedures
• Demonstrate proficiency in the technical aspects of Spyglass Percutaneous Endobiliary Procedures
• Discuss the potential complications of Spyglass Percutaneous Endobiliary Procedures 

9:10-10:10 |Villeray / De Tourny

Tech& Nurses: Stroke talk
Speaker(s): Dr. Nevin de Korompay

At the end of the session the participant will be able to:

• Review evidence Behind EVT
• Recognize equipment and technical details of EVT 
• Understand nursing perspective of developing an EVT program

10:10-10:30 Break

Potpourri

10:30-10:40 |Palais-Kent

Top IR Papers in IR for 2022
Speaker(s): Dr. John Kachura

At the end of the session the participant will be able to:

• Identify the latest evidence-based advances in interventional radiology, as presented in the top papers of 2022.
• List changes to the clinical practice to be made or maintained based on most current data presented
• Identify areas of further needed research and technical advancement in the field of IR 

10:40-10:55 |Palais-Kent

Peritoneal Dialysis
Speaker(s): Dr. Guillaume Garneau

At the end of the session the participant will be able to:

• Demonstrate the advantages of PD over other types of dialysis
• Utilize the technical basics of PD insertion in radiology and its benefits over surgical approach
• Recognize the main complications related to the technique 

10:55-11:10 |Palais-Kent

Thoracic Duct Embolization Techniques
Speaker(s): Dr. François Côté

At the end of the session the participant will be able to:

• Identify the main indications for a thoracic duct intervention.
• Describe the different imaging modalities that can be used to image the thoracic duct.
• Review the approaches (material and techniques) that can be considered to reach it for the intervention (embolization, stenting, drainage) 

11:10-11:25 |Palais-Kent

Cryoneurolysis
Speaker(s): Dr. Leandro Cardarelli Leite

At the end of the session the participant will be able to:

• Describe the indications and contraindications for cryoneurolysis
• Demonstrate proficiency in the technical aspects of performing cryoneurolysis
• Discuss the potential risks and complications of cryoneurolysis and describe strategies for mitigating and managing these complications 

11:25-11:40 |Palais-Kent

3D US to Improve Guidance Accuracy for Thermal Ablation
Speaker(s): Dr. Derek Cool

At the end of the session the participant will be able to:

• Describe the limitations of conventional 2D ultrasound for percutaneous ablation guidance
• Describe how 3D ultrasound can be used for volumetric assessment of solid abdominal organs during percutaneous ablation.
• Describe potential uses of 3D ultrasound for tumour identification, ablation needle guidance and verification of needle position. 

11:40-11:50 |Palais-Kent

Discussions

11:50-12:00 |Palais-Kent

Closing Remarks
Dr. Tara Graham, Dr. Alessandra Cassano-Bailey, Dr. Veronique Caty, Dr. Gerald Gahide, Dr. Stefan Pryzbojewski